$33.42 -0.07 (%) Medicines Co - NASDAQ

Dec. 2, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC

    Investors Business Daily | Dec. 1, 2016 | 14:14PM EST
  2. Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved

    TalkMarkets | Nov. 16, 2016 | 15:30PM EST
  3. On The Fly: After Hours Movers - 11/8

    TalkMarkets | Nov. 8, 2016 | 02:44AM EST
  4. Biotech Stock Roundup: Ariad Down On Drug Pricing Tweet, Regeneron Study On Clinical Hold

    TalkMarkets | Oct. 19, 2016 | 14:27PM EST
  5. Jefferies Sees 'Attractive Buying Opportunities' In Biotech

    TalkMarkets | Oct. 18, 2016 | 10:16AM EST
  6. Battleground: Alnylam Plunges After Revusiran Pulled, But Some See Opportunity

    TalkMarkets | Oct. 6, 2016 | 19:50PM EST
  7. Medicines Co. up on sale talk

    IBD | Jan. 20, 2016 | 18:40PM EST
  8. Mid-Afternoon Market Update: Dow Falls Over 400 Points; Advanced Micro Devices Shares Drop After Disappointing Guidance

    Benzinga | Jan. 20, 2016 | 14:48PM EST
  9. Medicines Company Spikes On Report Of Possible Sale

    IBD | Jan. 20, 2016 | 12:59PM EST
  10. Medicines Co Up For Sale? Bloomberg Info Comes Day After Benzinga Report; Companies Decline Comment

    Benzinga | Jan. 20, 2016 | 10:56AM EST
  11. The Medicines Company Announces Investigational Lipid Modulating Agent, MDCO-216, Phase 1 Data Published in European Heart Journal- Cardiovascular Pharmacotherapy

    Benzinga | Dec. 14, 2015 | 20:10PM EST
  12. Breakaway Gaps By Stocks Can Be Scary But Profitable

    IBD | Dec. 3, 2015 | 17:58PM EST
  13. Benzinga's Top Initiations

    Benzinga | Nov. 4, 2015 | 10:28AM EST
  14. Lilly Kills 'High Risk/High Reward' Cholesterol Drug

    IBD | Oct. 12, 2015 | 09:42AM EST
  15. The Medicines Company Announces BARDA Exercises Next Option on Contract for Support of the Development of CARBAVANCE® (meropenem/RPX7009) for Drug-Resistant Gram-Negative Pathogens

    Benzinga | Oct. 1, 2015 | 06:03AM EST
  16. Mid-Afternoon Market Update: NASDAQ Down 1.3%; Medicines Company Shares Gain Following Announcement Of Positive ALN-PCSsc Study Results

    Benzinga | Aug. 31, 2015 | 14:52PM EST
  17. Mid-Day Market Update: Crude Oil Surges 5.5%; ConforMIS Shares Tumble

    Benzinga | Aug. 31, 2015 | 12:05PM EST
  18. Benzinga's Volume Movers

    Benzinga | Aug. 31, 2015 | 09:42AM EST
  19. Mid-Morning Market Update: Markets Open Lower; Carlyle Group To Acquire Blyth For $6/Share

    Benzinga | Aug. 31, 2015 | 09:22AM EST
  20. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 31, 2015 | 07:14AM EST
  21. Benzinga's Top Upgrades

    Benzinga | Aug. 28, 2015 | 08:17AM EST
  22. The Medicines Company Announces Participation at 2015 European Society of Cardiology Congress in London, Will Present Cardiovascular Product Portfolio Results

    Benzinga | Aug. 24, 2015 | 06:01AM EST
  23. Volume And Volatility Alert: Medicines Company

    Benzinga | Aug. 14, 2015 | 06:15AM EST
  24. Regeneron/Sanofi PCSK9 Cholesterol Drug Wins FDA OK

    IBD | Jul. 24, 2015 | 15:11PM EST
  25. Medicines Co. gets upgrade

    IBD | Jul. 6, 2015 | 17:44PM EST
  26. Medicines Co., Eagle Pharma Up On Analyst Actions

    IBD | Jul. 6, 2015 | 11:18AM EST
  27. The Medicines Company Announces FDA Approval of KENGREAL as an Adjunct to Percutaneous Coronary Intervention for Reducing Thrombotic Events

    Benzinga | Jun. 22, 2015 | 14:06PM EST
  28. Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, Medicines Co Cangrelor ...

    GuruFocus | Apr. 16, 2015 | 16:30PM EST
  29. FDA Advisory Committee Recommends Approval of The Medicines Company's Antiplatelet Therapy Cangrelor

    Benzinga | Apr. 15, 2015 | 16:15PM EST
  30. Blood clot preventer gets nod

    IBD | Apr. 13, 2015 | 17:53PM EST
  31. Earnings Scheduled For February 18, 2015

    Benzinga | Feb. 18, 2015 | 05:08AM EST
  32. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD | Feb. 9, 2015 | 16:53PM EST
  33. Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

    Benzinga | Jan. 22, 2015 | 12:27PM EST
  34. Benzinga's Top Upgrades

    Benzinga | Jan. 21, 2015 | 08:47AM EST
  35. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  36. What Investors Should Expect From Rockwell Medical's Next FDA Decision

    Benzinga | Jan. 7, 2015 | 16:22PM EST
  37. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops Estimates

    Benzinga | Jan. 7, 2015 | 10:59AM EST
  38. Morning Market Losers

    Benzinga | Jan. 7, 2015 | 09:50AM EST
  39. Tuesday's After-Hours Movers

    Benzinga | Jan. 6, 2015 | 17:10PM EST
  40. The Medicines Company Surges Amid Credit Suisse Upgrade

    Benzinga | Nov. 20, 2014 | 10:16AM EST
  41. US Stock Futures Surge Ahead Of Earnings, ADP Data

    Benzinga | Nov. 5, 2014 | 07:18AM EST
  42. The Medicines Company Announces First Patient Enrollment In Phase 3 Studies Of CARBAVANCE in Development For The Treatment Of Serious Bacterial Infections Due To Gram-Negative Bacteria

    Benzinga | Nov. 5, 2014 | 06:36AM EST
  43. Midday Gainers From October 28: Buffalo Wild Wings, Integrated Device Technology, Cliffs Natural Resources And More

    Benzinga | Oct. 28, 2014 | 12:22PM EST
  44. Morning Market Movers

    Benzinga | Oct. 28, 2014 | 08:48AM EST
  45. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 15:58PM EST
  46. BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal Clinical Infectious Diseases

    Benzinga | Oct. 9, 2014 | 15:53PM EST
  47. Actavis Expands Antibiotics Presence With Durata Buy

    IBD | Oct. 6, 2014 | 09:58AM EST
  48. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga | Jun. 10, 2014 | 10:04AM EST
  49. Benzinga's Top Downgrades

    Benzinga | Apr. 17, 2014 | 07:02AM EST
  50. Benzinga's Top Downgrades

    Benzinga | Apr. 2, 2014 | 07:03AM EST
Trading Center